| Faricimab- Can it Reset the Recent Safety Doomed Innovations in Retinal Pharmacotherapy? | Ashish Sharma | 1–3 |
| Assessment of Retinal, Choroidal and Retinal Nerve Fiber Layer Thicknesses in Inflammatory Bowel Diseases | Mustafa Doğan, Serkan Özcan, Gürsel Acartürk, Mehmet Cem Sabaner, Elif Ertan, Mehmet Akif Seylan | 4–8 |
| Systemic Vascular Endothelial Function in Patients with Central Retinal Vein Occlusion | Orhan Altunel, Hasan Basri Arifoglu, Eyüp Özkan, Ebru Altunel, Necati Duru, Mustafa Ata | 9–14 |
| Comparison of Therapeutic Efficacy on Grid Laser Photocoagulation Combined with Aflibercept and Ranibizumab as Pro re Nata Regimen for Macular Edema Secondary to Branch Retinal Vein Occlusion | Buğra Karasu, Aslan Aykut | 15–23 |
| RNFL, GC-IPL and Choroidal Thickness in Non- Proliferative Diabetic Retinopathy | Erol Erkan, Sema Dündar | 24–31 |
| Treatment Approaches in Patients with Advanced Diabetic Eye Disease | Utku Limon, Betul Ilkay Akcay | 32–38 |
| Outcomes of Dexamethasone Implant Treatment in Patients with Diabetic Macula Edema Anatomically Unresponsive to Intravitreal Bevacizumab Treatment: Early Switch to Dexamethasone Study | Gökhan Demir, Abdullah Özkaya, Fatih Çoban, Ümit Çallı, Uğur Tunç | 39–43 |
| Correlations of Optic Disc Morphological Parameters with Peripapillary Choroidal Thickness and Retinal Vessel Caliber Measurements | Gökhan Pekel, Gülin Tuğba Ongun, Evre Pekel, Osman Parç, Önder Demirtaş, Emine Şeker Ün, Ebru Nevin Çetin | 44–49 |
| Factors Affecting the Visual Acuity and Anatomic Recovery in the Treatment of Diabetic Macular Edema | Naciye Kabataş, Osman Çelikay | 50–55 |
| Can CHADS2 and CHA2DS2-VASc Scores be Used to Predict Clinical Outcomes in Patients with Age-Related Macular Degeneration? | Ersin Muhafiz, Şerif Nizamoğulları, İbrahim Rencüzoğulları, Erdinc Bozkurt | 56–61 |
| Peripheral Facial Paralysis in a Newborn with Charge Syndrome | Ozdemir Ozdemir, Gulcin Ergeldi, Abdullah Bayrak, Eyyup Karahan, Aysegul Arman |